Literature DB >> 18511145

High loading efficiency and tunable release of plasmid DNA encapsulated in submicron particles fabricated from PLGA conjugated with poly-L-lysine.

Jeremy S Blum1, W Mark Saltzman.   

Abstract

Poly(lactic-co-glycolic acid) (PLGA) particles have been widely explored as vehicles for delivery of plasmid DNA to mammalian cells both in vitro and in vivo. Achieving high incorporation efficiencies and control over release kinetics are significant challenges in encapsulating hydrophilic molecules such as DNA within submicron particles fabricated from PLGA. This study explored two modifications in the preparation of submicron particles to specifically address these challenges. Firstly, we compared homogenization and sonication as energy sources for emulsification. It was demonstrated that particles prepared with homogenization resulted in higher encapsulation efficiency and a linear release profile of DNA as compared to particles prepared with sonication, which exhibited lower encapsulation efficiency and a burst release. Also investigated was conjugation of poly-L-lysine to PLGA (PLGA-PLL) to create an electrostatically favorable interaction between the carrier material and the DNA. Particles fabricated with high weight percentages of PLGA-PLL/PLGA resulted in remarkably increased loading (>90%). Additionally, the release profile could be dictated by the quantity of PLGA-PLL incorporated into the particles. Particles incubated in vitro on COS-7 cells were able to transfect cells. These results demonstrated that DNA encapsulation and release were modulated by the method of fabrication.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18511145      PMCID: PMC2494593          DOI: 10.1016/j.jconrel.2008.04.002

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  26 in total

1.  Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery.

Authors:  A M Tinsley-Bown; R Fretwell; A B Dowsett; S L Davis; G H Farrar
Journal:  J Control Release       Date:  2000-05-15       Impact factor: 9.776

2.  Cationic microparticles: A potent delivery system for DNA vaccines.

Authors:  M Singh; M Briones; G Ott; D O'Hagan
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

3.  The effect of CTAB concentration in cationic PLG microparticles on DNA adsorption and in vivo performance.

Authors:  Manmohan Singh; Mildred Ugozzoli; Maylene Briones; Jina Kazzaz; Elawati Soenawan; Derek T O'Hagan
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

4.  Poly(L-lysine)-g-poly(D,L-lactic-co-glycolic acid) micelles for low cytotoxic biodegradable gene delivery carriers.

Authors:  Ji Hoon Jeong; Tae Gwan Park
Journal:  J Control Release       Date:  2002-07-18       Impact factor: 9.776

5.  Two methods for quantifying DNA extracted from poly(lactide-co-glycolide) microspheres.

Authors:  S P Barman; L Lunsford; P Chambers; M L Hedley
Journal:  J Control Release       Date:  2000-12-03       Impact factor: 9.776

6.  Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles.

Authors:  Xiaowen He; Lei Jiang; Fang Wang; Zhenyu Xiao; Jun Li; Liu Shankui Liu; Dean Li; Ding Ren; Xiaoqin Jin; Kai Li; Yin He; Ke Shi; Yingjun Guo; Yanan Zhang; Shuhan Sun
Journal:  J Control Release       Date:  2005-10-03       Impact factor: 9.776

7.  Encapsulated plasmid DNA treatment for human papillomavirus 16-associated anal dysplasia: a Phase I study of ZYC101.

Authors:  Barbara Klencke; Mark Matijevic; Robert G Urban; Janet L Lathey; Mary Lynne Hedley; Michael Berry; Joe Thatcher; Vivian Weinberg; Jennifer Wilson; Teresa Darragh; Naomi Jay; Maria Da Costa; Joel M Palefsky
Journal:  Clin Cancer Res       Date:  2002-05       Impact factor: 12.531

8.  Poly-L-lysine-coated nanoparticles: a potent delivery system to enhance DNA vaccine efficacy.

Authors:  Gabriela Minigo; Anja Scholzen; Choon K Tang; Jennifer C Hanley; Martha Kalkanidis; Geoffrey A Pietersz; Vasso Apostolopoulos; Magdalena Plebanski
Journal:  Vaccine       Date:  2006-10-10       Impact factor: 3.641

9.  A simple synthetic route to the formation of a block copolymer of poly(lactic-co-glycolic acid) and polylysine for the fabrication of functionalized, degradable structures for biomedical applications.

Authors:  E B Lavik; J S Hrkach; N Lotan; R Nazarov; R Langer
Journal:  J Biomed Mater Res       Date:  2001-05-01

10.  Single dose of a vaccine based on DNA encoding mycobacterial hsp65 protein plus TDM-loaded PLGA microspheres protects mice against a virulent strain of Mycobacterium tuberculosis.

Authors:  K M Lima; S A Santos; V M F Lima; A A M Coelho-Castelo; J M Rodrigues; C L Silva
Journal:  Gene Ther       Date:  2003-04       Impact factor: 5.250

View more
  39 in total

1.  Octa-functional PLGA nanoparticles for targeted and efficient siRNA delivery to tumors.

Authors:  Jiangbing Zhou; Toral R Patel; Michael Fu; James P Bertram; W Mark Saltzman
Journal:  Biomaterials       Date:  2011-10-19       Impact factor: 12.479

Review 2.  Systemic delivery to central nervous system by engineered PLGA nanoparticles.

Authors:  Qiang Cai; Long Wang; Gang Deng; Junhui Liu; Qianxue Chen; Zhibiao Chen
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

3.  Effect of drug release kinetics on nanoparticle therapeutic efficacy and toxicity.

Authors:  Manish Sethi; Rohit Sukumar; Shrirang Karve; Michael E Werner; Edina C Wang; Dominic T Moore; Sonya R Kowalczyk; Liangfang Zhang; Andrew Z Wang
Journal:  Nanoscale       Date:  2014-01-14       Impact factor: 7.790

4.  Preparation of particulate polymeric therapeutics for medical applications.

Authors:  Jia Zhuang; Ronnie H Fang; Liangfang Zhang
Journal:  Small Methods       Date:  2017-07-25

5.  Poly(lactide-co-glycolide) nanoparticle assembly for highly efficient delivery of potent therapeutic agents from medical devices.

Authors:  Catherine T Lo; Paul R Van Tassel; W Mark Saltzman
Journal:  Biomaterials       Date:  2010-02-10       Impact factor: 12.479

6.  Gene delivery by surface immobilization of plasmid to tissue-engineering scaffolds.

Authors:  D M Salvay; M Zelivyanskaya; L D Shea
Journal:  Gene Ther       Date:  2010-05-20       Impact factor: 5.250

7.  Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo.

Authors:  N A McNeer; E B Schleifman; A Cuthbert; M Brehm; A Jackson; C Cheng; K Anandalingam; P Kumar; L D Shultz; D L Greiner; W Mark Saltzman; P M Glazer
Journal:  Gene Ther       Date:  2012-10-18       Impact factor: 5.250

8.  Surface modified poly(β amino ester)-containing nanoparticles for plasmid DNA delivery.

Authors:  Rachel J Fields; Christopher J Cheng; Elias Quijano; Caroline Weller; Nina Kristofik; Nha Duong; Christopher Hoimes; Marie E Egan; W Mark Saltzman
Journal:  J Control Release       Date:  2012-10-05       Impact factor: 9.776

9.  Targeted genome modification via triple helix formation.

Authors:  Adele S Ricciardi; Nicole A McNeer; Kavitha K Anandalingam; W Mark Saltzman; Peter M Glazer
Journal:  Methods Mol Biol       Date:  2014

Review 10.  Nanotechnology for delivery of peptide nucleic acids (PNAs).

Authors:  Anisha Gupta; Raman Bahal; Meera Gupta; Peter M Glazer; W Mark Saltzman
Journal:  J Control Release       Date:  2016-01-08       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.